No Detail Found!

Changes in portal vein hemodynamics evaluated by duplex ultrasound in chronic hepatitis C patients treated with interferon and ribavirin.

Author(s)
Samina Akhter National Institute of Child Health (NICH), Karachi, Pakistan
Saima Amin Jinnah Postgraduate Medical Centre/hospital, Karachi, Pakistan
Muhammad Imran Hameed Daula Pakistan Navy Ship (PNS) SHIFA, Karachi, Pakistan
Abstract
Objective To determine the changes brought about by interferon-ribavirin therapy in the portal blood flow velocity determined by Duplex ultrasound in patients of chronic hepatitis C (CHC) and to assess the clinical significance of these changes to monitor effects of combination therapy. Patients and Methods This Quasi experimental study was carried out from May 2008 to June 2010 at Department of Radiology at Jinnah Postgraduate Medical Centre (JPMC) hospital, Karachi, Pakistan. Twenty patients (13 female and 7 male; mean age 34.35 years) with CHC were included in the study. They underwent liver biopsy and received Interferon­Ribavirin combination therapy at JPMC. The study also included twenty healthy adult age matched volunteers as control subjects. The effectiveness of interferon-ribavirin combination therapy treatment was evaluated by serum ALT levels, hepatitis C virus RNA PCR and sonographically by measuring Portal blood flow velocity at the porta hepatis on three occasions: Before initiation of therapy (pre IFN), two weeks after the initiation of therapy (Week-2) and twenty four weeks after the initiation of therapy (Week-24).Results: The patients with chronic hepatitis C in whom Interferon-Ribavirin combination therapy resulted in complete or effective elimination of the viruses showed statistically significant (p?0.001) increase in portal blood flow velocity at the end of the treatment compared with that before Interferon-Ribavirin combination therapy and also compared to those patients in whom the Interferon-Ribavirin combination therapy did not produce any response. Conclusion: Doppler sonography is a sensitive and clinically useful diagnostic modality for evaluating the effect of Interferon-Ribavirin combination therapy in patients of chronic hepatitis C.
Publication Details
Page(s) 390-394
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 37, Issue: 4, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

25

Views